Multiplex Assay Kit for Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay)

Apo-C1; Truncated apolipoprotein C-I

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-88 79
EDTA plasma(n=5) 80-94 84
heparin plasma(n=5) 87-94 90

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-98% 99-105% 78-95% 95-105%
EDTA plasma(n=5) 95-103% 85-93% 79-97% 78-104%
heparin plasma(n=5) 98-105% 97-104% 97-105% 88-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:APOC1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PROTEOMICS - Clinical Applications Proteomic and genomic analyses suggest the association of Apolipoprotein C1 with abdominal aortic aneurysm Onlinelibrary: prca.201300119
Journal of Dairy Science Colostrum and milk protein rankings and ratios of importance to neonatal calf health using a proteomics approach pubmed:28189329
RESPIRATORY RESEARCH The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation … Pubmed: 33148285
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA252Hu01 Recombinant Apolipoprotein C1 (APOC1) Positive Control; Immunogen; SDS-PAGE; WB.
APA252Hu01 Active Apolipoprotein C1 (APOC1) Cell culture; Activity Assays.
APA252Hu02 Active Apolipoprotein C1 (APOC1) Cell culture; Activity Assays.
RPA252Hu02 Recombinant Apolipoprotein C1 (APOC1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA252Hu01 Polyclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC/IF; FCM
PAA252Hu02 Polyclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC; IP.
LAA252Hu71 Biotin-Linked Polyclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC.
MAA252Hu21 Monoclonal Antibody to Apolipoprotein C1 (APOC1) WB
MAA252Hu23 Monoclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC; IP.
MAA252Hu22 Monoclonal Antibody to Apolipoprotein C1 (APOC1) WB; IHC; ICC; IP.
FAA252Hu02 Anti-Apolipoprotein C1 (APOC1) Monoclonal Antibody FCM
FAA252Hu04 Anti-Apolipoprotein C1 (APOC1) Monoclonal Antibody Flow cytometry.
SEA252Hu ELISA Kit for Apolipoprotein C1 (APOC1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA252Hu Multiplex Assay Kit for Apolipoprotein C1 (APOC1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CGA252Hu02 cDNA of Apolipoprotein C1 (APOC1) PCR; Protein Expression; etc.